abstract |
The present invention relates to new dihydropteridinones of the formula (I)wherein the groups X, R<1>, R<2>, R<3>, R<4>, R<5 >and R<7 >have the meanings given in the claims and the specification, the isomers thereof, processes and intermediates for preparing these dihydropteridinones as well as the use thereof as pharmaceutical compositions. |